Microbot Medical Inc. (MBOT)

NASDAQ: MBOT · IEX Real-Time Price · USD
2.14
-0.11 (-4.89%)
At close: Mar 21, 2023, 4:00 PM
2.13
-0.01 (-0.47%)
After-hours: Mar 21, 2023, 4:41 PM EDT
-4.89%
Market Cap 16.89M
Revenue (ttm) n/a
Net Income (ttm) -14.03M
Shares Out 7.89M
EPS (ttm) -1.97
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 24,121
Open 2.27
Previous Close 2.25
Day's Range 2.12 - 2.27
52-Week Range 2.12 - 6.77
Beta 3.24
Analysts Buy
Price Target 20.40 (+853.27%)
Earnings Date Mar 30, 2023

About MBOT

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 paten... [Read more]

Sector Healthcare
Founded 2010
Employees 20
Stock Exchange NASDAQ
Ticker Symbol MBOT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for MBOT stock is "Buy." The 12-month stock price forecast is $20.4, which is an increase of 853.27% from the latest price.

Price Target
$20.4
(853.27% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Microbot Medical Launches Presence in the United Kingdom as Highly Accomplished Consultant Interventional Radiologist Professor Mark W. Little Joins its Scientific Advisory Board as Efforts to Commercialize the LIBERTY® Robotic System Continue to Accelerate

Internationally Recognized Academic Leader Awarded the National Institute for Health Research (NIHR) Research Rising Star Award, and Cardiovascular and Interventional Radiology (CVIR) Editors Medal In...

5 days ago - GlobeNewsWire

Microbot Medical Increases Presence in the EU with the Addition of Greece-based Key Opinion Leader Stavros Spiliopoulos, MD, PhD, EBIR-ES, FCIRSE, to its Scientific Advisory Board

Internationally Recognized and Awarded Interventional Radiologist Enhances Depth of Expertise as the LIBERTY® Robotic System Races Towards Regularity and Commercialization Objectives Internationally R...

1 week ago - GlobeNewsWire

Microbot Medical's Chief Medical Officer Dr. Eyal Morag to Highlight Performance, Safety and Usability Benefits of the LIBERTY® Robotic System During Podium Presentation at Prestigious Robotics Conference

HINGHAM, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic System, the first single-use endovascular robotic system, today announced...

1 week ago - GlobeNewsWire

Microbot Medical Meeting with Key Opinion Leaders, Hospital Administrators, and Potential Strategic and Commercial Partners at the Society of Interventional Radiologist Annual Meeting

Continues to Raise Awareness of the LIBERTY® Robotic System Ahead of Commercialization Plans Continues to Raise Awareness of the LIBERTY® Robotic System Ahead of Commercialization Plans

3 weeks ago - GlobeNewsWire

Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next “Access-Ability Live by MBOT” Webinar Series

Dr. Giora Weisz, a Practicing Interventional Cardiologist and Clinical Researcher who was One of the Early Users of Robotic-Enhanced Coronary Interventions, as well as Navigation and Positioning Techn...

1 month ago - GlobeNewsWire

Microbot Medical Announces MedTech Industry Veteran Joe Mullings will Moderate the Next ‘Access-Ability Live by MBOT' Webinar

Panel of Proven Medical Device Entrepreneurs and Surgical Robotics Pioneers Will Share Their Personal Experiences of Taking Innovative New Technologies from Development to Commercialization

2 months ago - GlobeNewsWire

Microbot Medical Inc. (MBOT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Microbot Medical Inc. (MBOT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreemen...

3 months ago - Zacks Investment Research

Microbot Medical Announces the Participation of a Key Opinion Leader in the Endovascular Robotics Space at the Next “Access-Ability Live by MBOT” Webinar Series

The Webinar, Which is Suitable to All Stakeholders Interested in the Future of Endovascular Robotics, Will be Held on Wednesday, December 21, 2022, at 1:00pm ET

3 months ago - GlobeNewsWire

Microbot Medical's Proprietary LIBERTY® Robotic System Receives Third Patent Allowance in Israel

Pace of Jurisdictional Allowances Parallels Pre-Clinical and Regulatory Progress Pace of Jurisdictional Allowances Parallels Pre-Clinical and Regulatory Progress

3 months ago - GlobeNewsWire

Microbot Medical Announces New Webinar Series to Engage Stakeholders with Experts in the Healthcare Space

Th e “ Access-Ability Live” by MBOT will build an online community of healthcare industry leaders who are interested in robotics to come together and share their opinion and experience

4 months ago - GlobeNewsWire

Microbot Medical Receives Additional Patent Allowance in Israel for the LIBERTY® Robotic System

Corresponding Application Previously Granted in the U.S. as the Company Continues to Create Global Barriers to Entry for its Novel Technology Corresponding Application Previously Granted in the U.S. a...

4 months ago - GlobeNewsWire

Microbot Medical Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

HINGHAM, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has closed its previously announced registered direct offering with a single institutiona...

5 months ago - GlobeNewsWire

Microbot Medical Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

HINGHAM, Mass., Oct. 21, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into a definitive agreement with a single institutional investor for the purc...

5 months ago - GlobeNewsWire

Microbot Medical Accomplishes the Next-Step in the Regulatory Process for the LIBERTY® Robotic System

HINGHAM, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that it has submitted the anticipated follow-up pre-submission package for the LIBERTY® Robotic System...

5 months ago - GlobeNewsWire

Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System

HINGHAM, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced a significant development milestone as it completed the GLP animal study for the LIBERTY® Robotic Syste...

5 months ago - GlobeNewsWire

Microbot Medical Receives Patent Allowance in Israel for the LIBERTY® Robotic System

Complements Existing Allowance in the U.S. as Global Jurisdictions Recognize the Uniqueness of the Technology Complements Existing Allowance in the U.S. as Global Jurisdictions Recognize the Uniquenes...

5 months ago - GlobeNewsWire

Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices

Integration with the LIBERTY® Robotic System & One & Done™ Technology May Enable Future Acceleration of Robotic Adoption; Represents an Additional Growth Opportunity by Accessing the $500 Million Chro...

5 months ago - GlobeNewsWire

Microbot Medical Announce Strategic Addition to Scientific Advisory Board Appointment

Award-Winning Interventional Radiologist in the NY Metro Area Adds Significant Depth and Experience Award-Winning Interventional Radiologist in the NY Metro Area Adds Significant Depth and Experience

6 months ago - GlobeNewsWire

Microbot Medical Enhances its Scientific Advisory Board (SAB) with its Newest Member Dr. Vincent Vidal

Prominent France based interventional radiologist to leverage his expertise to assist the Company to achieve its future objective for the LIBERTY® Robotic System Prominent France based interventional ...

6 months ago - GlobeNewsWire

Microbot Medical to Review Recent Progress During H.C. Wainwright's 24th Annual Global Investment Conference

Company Continues to Achieve Primary Objectives for its LIBERTY® Robotic System in 2022 Company Continues to Achieve Primary Objectives for its LIBERTY® Robotic System in 2022

6 months ago - GlobeNewsWire

Microbot Medical Commenced its First Step in the Anticipated Regulatory Process for its LIBERTY® Robotic System

GLP Pre-Clinical Trial Commenced at a Leading Research Institute by Global Leaders in the Endovascular Space GLP Pre-Clinical Trial Commenced at a Leading Research Institute by Global Leaders in the E...

6 months ago - GlobeNewsWire

Microbot Medical Strengthen its Scientific Advisory Board with the Recent Addition of Dr. Sebastian Flacke

A global leader in the endovascular space will collaborate with the Company as it goes through the regulatory process and future commercialization

6 months ago - GlobeNewsWire

Microbot Medical Confirms GLP Pre-Clinical Trial is on Track to Commence Later this Month

HINGHAM, Mass., Sept. 02, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced, as part of the preparation for its anticipated U.S. Food and Drug Administration (FDA) and CE Mark su...

7 months ago - GlobeNewsWire

Microbot Medical to Present the Self-Cleaning Shunt at the 16th Asian Australasian Congress of Neurological Surgeons

HINGHAM, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that it will be presenting the Company's Self-Cleaning Shunt (SCS) at the 16th Asian Australasian Cong...

7 months ago - GlobeNewsWire